Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes

详细信息    查看全文

• 作者：Kenneth H Mellits (1)
  Ian F Connerton (1)
  Michael F Loughlin (1)
  Peter Clarke (2)
  Julie Smith (3)
  Eleanor Dillon (1)
  Phillippa L Connerton (1)
  Francis Mulholland (4)
  Christopher J Hawkey (3)
  
• 刊名：BMC Microbiology
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：9
• 期：1
• 全文大小：1307KB
• 参考文献：1. Snelling WJ, Matsuda M, Moore JE, Dooley JS: Campylobacter jejuni. / Lett Appl Microbiol 2005,41(4):297-02. j.1472-765X.2005.01788.x">CrossRef
  2. Young KT, Davis LM, Dirita VJ: Campylobacter jejuni: molecular biology and pathogenesis. / Nat Rev Microbiol 2007,5(9):665-79. CrossRef
  3. Jorgensen F, Bailey R, Williams S, Henderson P, Wareing DR, Bolton FJ, Frost JA, Ward L, Humphrey TJ: Prevalence and numbers of Salmonella and Campylobacter spp. on raw, whole chickens in relation to sampling methods. / Int J Food Microbiol 2002,76(1-):151-64. CrossRef
  4. Hughes RA, Cornblath DR: Guillain-Barre syndrome. / Lancet 2005,366(9497):1653-666. CrossRef
  5. Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, / et al.: Immunoproliferative small intestinal disease associated with Campylobacter jejuni. / N Engl J Med 2004,350(3):239-48. CrossRef
  6. Guerry P: Campylobacter flagella: not just for motility. / Trends Microbiol 2007,15(10):456-61. j.tim.2007.09.006">CrossRef
  7. Smith JL, Bayles DO: The contribution of cytolethal distending toxin to bacterial pathogenesis. / Crit Rev Microbiol 2006,32(4):227-48. CrossRef
  8. Mellits KH, Mullen J, Wand M, Armbruster G, Patel A, Connerton PL, Skelly M, Connerton IF: Activation of the transcription factor NF-kappaB by Campylobacter jejuni. / Microbiology 2002,148(Pt 9):2753-763.
  9. Brasier AR: The NF-kappaB regulatory network. / Cardiovasc Toxicol 2006,6(2):111-30. CrossRef
  10. Kirkland SC: Dome formation by a human colonic adenocarcinoma cell line (HCA-7). / Cancer Res 1985,45(8):3790-795.
  11. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, / et al.: The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. / Nature 2000,403(6770):665-68. CrossRef
  12. Kennedy RE, Kerns RT, Kong X, Archer KJ, Miles MF: SScore: an R package for detecting differential gene expression without gene expression summaries. / Bioinformatics 2006,22(10):1272-274. CrossRef
  13. Zhang J, Carey V, Gentleman R: An extensible application for assembling annotation for genomic data. / Bioinformatics 2003,19(1):155-56. CrossRef
  14. Huggett J, Dheda K, Bustin S, Zumla A: Real-time RT-PCR normalisation; strategies and considerations. / Genes Immun 2005,6(4):279-84. j.gene.6364190">CrossRef
  15. Colgan T, Lambert JR, Newman A, Luk SC: Campylobacter jejuni enterocolitis. A clinicopathologic study. / Arch Pathol Lab Med 1980,104(11):571-74.
  16. Beltinger J, Brough J, Skelly MM, Thornley J, Spiller RC, Stack WA, Hawkey CJ: Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. 2008,14(48):7345-2.
  17. Konkel ME, Kim BJ, Rivera-Amill V, Garvis SG: Identification of proteins required for the internalization of Campylobacter jejuni into cultured mammalian cells. / Adv Exp Med Biol 1999, 473:215-24.
  18. Hickey TE, McVeigh AL, Scott DA, Michielutti RE, Bixby A, Carroll SA, Bourgeois AL, Guerry P: Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. / Infect Immun 2000,68(12):6535-541. CrossRef
  19. Hinata K, Gervin AM, Jennifer Zhang Y, Khavari PA: Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. / Oncogene 2003,22(13):1955-964. j.onc.1206198">CrossRef
  20. Yamamoto Y, Gaynor RB: IkappaB kinases: key regulators of the NF-kappaB pathway. / Trends Biochem Sci 2004,29(2):72-9. j.tibs.2003.12.003">CrossRef
  21. Heyninck K, Kreike MM, Beyaert R: Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. / FEBS Lett 2003,536(1-):135-40. CrossRef
  22. Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R: Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2. / J Biol Chem 2001,276(32):30216-0223. jbc.M100048200">CrossRef
  23. Jones MA, Totemeyer S, Maskell DJ, Bryant CE, Barrow PA: Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni. / Infect Immun 2003,71(5):2626-633. CrossRef
  24. Rinella ES, Eversley CD, Carroll IM, Andrus JM, Threadgill DW, Threadgill DS: Human epithelial-specific response to pathogenic Campylobacter jejuni. / FEMS Microbiol Lett 2006,262(2):236-43. j.1574-6968.2006.00396.x">CrossRef
  25. Huang X, Guo B: Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. / Cancer Res 2006,66(18):9245-251. CrossRef
  26. Yan N, Shi Y: Mechanisms of apoptosis through structural biology. / Annu Rev Cell Dev Biol 2005, 21:35-6. CrossRef
  27. Werner MH, Wu C, Walsh CM: Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. / Cell Cycle 2006,5(20):2332-338. CrossRef
  28. Wajant H, Scheurich P: Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. / Int J Biochem Cell Biol 2001,33(1):19-2. CrossRef
  29. Beyaert R, Heyninck K, Van Huffel S: A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. / Biochem Pharmacol 2000,60(8):1143-151. CrossRef
  30. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, / et al.: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. / Nature 1996,379(6563):349-53. CrossRef
  31. Kataoka T: The caspase-8 modulator c-FLIP. / Crit Rev Immunol 2005,25(1):31-8. CrossRef
  32. Li X, Yang Y, Ashwell JD: TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. / Nature 2002,416(6878):345-47. CrossRef
  33. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. / Genes Dev 1999,13(12):1501-512. CrossRef
  34. Arden KC: FoxO: linking new signaling pathways. / Mol Cell 2004,14(4):416-18. CrossRef
  35. Seoane J, Le HV, Shen L, Anderson SA, Massague J: Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. / Cell 2004,117(2):211-23. CrossRef
  36. Pagano M: Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis. / Mol Cell 2004,14(4):414-16. CrossRef
  37. Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, Feng Y, Sharp PA, Sonenberg N, White FM, / et al.: 14--3sigma controls mitotic translation to facilitate cytokinesis. / Nature 2007,446(7133):329-32. CrossRef
  38. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. / Nature 2004,432(7019):917-21. CrossRef
  39. Borregaard N, Cowland JB: Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. / Biometals 2006,19(2):211-15. CrossRef
  40. Sallenave JM: The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. / Respir Res 2000,1(2):87-2. CrossRef
  41. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC: Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. / Science 1999,286(5437):113-17. CrossRef
  42. Kloetzel PM: Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. / Nat Immunol 2004,5(7):661-69. CrossRef
  43. Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G: Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. / Blood 2000,96(8):2673-681.
  44. Li Q, Park PW, Wilson CL, Parks WC: Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. / Cell 2002,111(5):635-46. CrossRef
  45. Kullander K, Klein R: Mechanisms and functions of Eph and ephrin signalling. / Nat Rev Mol Cell Biol 2002,3(7):475-86. CrossRef
  46. Anton IM, Jones GE, Wandosell F, Geha R, Ramesh N: WASP-interacting protein (WIP): working in polymerisation and much more. / Trends Cell Biol 2007,17(11):555-62. j.tcb.2007.08.005">CrossRef
  47. Stanger O: Physiology of folic acid in health and disease. / Curr Drug Metab 2002,3(2):211-23. CrossRef
  48. Friedman CR, Neimann J, Wegener HC, Tauxe RV: Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. / Campylobacter / 2 Edition / (Edited by: Nachamkin I, Blaser MJ). Washington, DC ASM Press 2000, 121-38.
  49. Zhang SZ, Zhao XH, Zhang DC: Cellular and molecular immunopathogenesis of ulcerative colitis. / Cell Mol Immunol 2006,3(1):35-0.
  50. Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. / Am J Gastroenterol 2000,95(12):3452-457.
  51. Papadakis KA: Chemokines in inflammatory bowel disease. / Curr Allergy Asthma Rep 2004,4(1):83-9. CrossRef
  52. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ: Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis. / Clinical Science 1992,82(3):273-75.
  53. Cole AT, Pilkington BJ, McLaughlan J, Smith C, Balsitis M, Hawkey CJ: Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4. / Gut 1996,39(2):248-54. CrossRef
  54. Watanabe S, Yamakawa M, Hiroaki T, Kawata S, Kimura O: Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis. / Clin Immunol 2007,122(3):288-97. j.clim.2006.10.013">CrossRef
  55. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y: Increased expression of interleukin 17 in inflammatory bowel disease. / Gut 2003,52(1):65-0. CrossRef
  56. Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lonnroth I: Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening. / Inflamm Bowel Dis 2006,12(9):837-42. CrossRef
  57. McGovern D, Powrie F: The IL23 axis plays a key role in the pathogenesis of IBD. / Gut 2007,56(10):1333-336. CrossRef
  58. Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Tulassay Z, / et al.: ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. 2008,40(11):867-3.
  59. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. / Clin Exp Immunol 2007,149(3):480-86. j.1365-2249.2007.03439.x">CrossRef
  60. Rodriguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK: Novel genetic markers in inflammatory bowel disease. / World J Gastroenterol 2007,13(42):5560-570.
  61. Seidelin JB, Nielsen OH: Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis. / Apmis 2006,114(7-):508-17. j.1600-0463.2006.apm_116.x">CrossRef
  
• 作者单位：Kenneth H Mellits (1)
  Ian F Connerton (1)
  Michael F Loughlin (1)
  Peter Clarke (2)
  Julie Smith (3)
  Eleanor Dillon (1)
  Phillippa L Connerton (1)
  Francis Mulholland (4)
  Christopher J Hawkey (3)
  
  1. Division of Food Sciences, School of Biosciences, University of Nottingham, Sutton Bonington Campus, LE12 5RD, Loughborough, Leicestershire, UK
  2. MyCIB, School of Biosciences, University of Nottingham, Sutton Bonington Campus, LE12 5RD, Loughborough, Leicestershire, UK
  3. Wolfson Digestive Diseases Centre, University Hospital Nottingham, NG7 2UH, Nottingham, UK
  4. Institute of Food Research, Norwich Research Park, NR4 7UA, Colney, Norwich, UK
  
• ISSN：1471-2180

文摘

Background Campylobacter jejuni, the commonest cause of bacterial diarrhoea worldwide, can also induce colonic inflammation. To understand how a previously identified heat stable component contributes to pro-inflammatory responses we used microarray and real-time quantitative PCR to investigate the transcriptional response to a boiled cell extract of Campylobacter jejuni NCTC 11168. Results RNA was extracted from the human colonocyte line HCA-7 (clone 29) after incubation for 6 hours with Campylobacter jejuni boiled cell extract and was used to probe the Affymetrix Human Genome U133A array. Genes differentially affected by Campylobacter jejuni boiled cell extract were identified using the Significance Score algorithm of the Bioconductor software suite and further analyzed using the Ingenuity Pathway Analysis program. The chemokines CCL20, CXCL3, CXCL2, Interleukin 8, CXCL1 and CXCL6 comprised 6 of the 10 most highly up-regulated genes, all with Significance Scores ?10. Members of the Tumor Necrosis Factor α/Nuclear Factor-κB super-family were also significantly up-regulated and involved in the most significantly regulated signalling pathways (Death receptor, Interleukin 6, Interleukin 10, Toll like receptor, Peroxisome Proliferator Activated Receptor-γ and apoptosis). Ingenuity Pathway Analysis also identified the most affected functional gene networks such as cell movement, gene expression and cell death. In contrast, down-regulated genes were predominantly concerned with structural and metabolic functions. Conclusion A boiled cell extract of Campylobacter jejuni has components that can directly switch the phenotype of colonic epithelial cells from one of resting metabolism to a pro-inflammatory one, particularly characterized by increased expression of genes for leukocyte chemoattractant molecules.